Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 77 (RPL23AP77)

Target
RPL23AP77
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L23a pseudogene 77 (RPL23AP77) is one of many processed pseudogenes derived from the RPL23A gene, which encodes a component of the large (60S) ribosomal subunit[1][4]. Pseudogenes, including RPL23AP77, do not produce functional proteins and are generally considered non-coding genomic sequences. There is no evidence for a biological or therapeutic role for RPL23AP77, nor is it associated with disease or drug targeting. Its function, if any, may be limited to non-coding regulatory roles, but no such function has been described for this specific pseudogene[1][3][4]. RPL23A—distinct from RPL23AP77—is a functional gene that encodes a ribosomal protein involved in protein synthesis and has been studied for its role in growth regulation and immunity[1][4]. As with many ribosomal protein genes, numerous pseudogenes like RPL23AP77 exist throughout the genome, but they do not encode proteins and are not considered proper drug targets[1][4]. RPL23AP77 is a pseudogene, not a functional protein, receptor, enzyme, or therapeutic target. Therefore, it should not be classified as a biological or pharmacological target in scientific or pharmaceutical databases[1][4].

Other names
RPL23A_33_1589RPL23AP77

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 77 (RPL23AP77).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 77 (RPL23AP77).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call